complex perianal fistulas

December 20, 2017

Alofisel for Crohn’s Fistulas Receives EMA Recommendation for Marketing Authorization in EU

News

TiGenix received a European Medicines Agency (EMA) recommendation for the marketing authorization of Alofisel (darvadstrocel, Cx601) as an advanced therapy medicinal product (ATMP) for the treatment of complex perianal fistulas in people with ... Read more

October 10, 2017October 10, 2017

TiGenix Presents Positive Results of Potential Crohn’s Therapy, Announces Phase 3 Study

News

TiGenix will present positive results of Cx601 to treat complex perianal fistulas in Crohn’s disease patients at the upcoming World Congress of Gastroenterology ACG 2017 meeting in Orlando, Florida. The company will discuss ... Read more

June 16, 2017June 16, 2017

TiGenix Starts Global Phase 3 Trial to Evaluate Cx601 as a Treatment for Crohn’s Fistulas

News

TiGenix has started a pivotal Phase 3 clinical trial of Cx601’s ability to treat a complication of Crohn’s disease known as complex perianal fistulas. Fistulas are sores between the end of the bowel ... Read more